ULTRAPEX Trading Center Upgrades Core Trading Architecture to Enhance Platform Stability
New York, NY, Dec. 29, 2025 (GLOBE NEWSWIRE) -- ULTRAPEX Trading Center…
SI Group Announces Closing of Comprehensive Recapitalization, Positioning the Company for Accelerated Growth
Significant De-leveraging Transaction Resulting in Overall Debt Reduction of Approximately $1.7 Billion…
Mercedes star shines bright as Euro NCAPs final results deliver safer options for every buyer
LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET Â | Source: TScan Therapeutics, Inc. Treatment arm…
Medit recognized as the top brand in a global brand perception study by an external insights agency
Global sentiment analysis of 3,800 discussions from Reddit's r/Dentistry community highlights strong…
Sopra Steria recognised as “Leader” by NelsonHall for its ability to deploy GenAI in support of organisations’ operational transformation
PARIS, Nov. 28, 2025 /PRNewswire/ -- Sopra Steria, a major player in…
Cell Impact has been awarded gold medal by EcoVadis
KARLSKOGA, Sweden, Nov. 11, 2025 /PRNewswire/ -- Last year, Cell Impact was…
OMD NAMED BEST PERFORMING GLOBAL MEDIA NETWORK FOR THE TENTH CONSECUTIVE TIME
New RECMA Diagnostics Report Reveals OMD "Remains More than Ever the Leader"…
Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop
BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…